Opinion: SpaceX Will Be Mother Of All IPOs

The article argues that aerospace and defense IPO activity is accelerating, with 11 successful IPOs since the SPAC wave and more high-profile listings expected over the next 12-24 months. It highlights SpaceX as the potential largest IPO in history, reportedly targeting a $75 billion raise at a $1.75 trillion valuation, alongside Anduril's recent $4 billion Series H at a $60 billion valuation. The piece suggests strong investor demand and elevated valuations are reshaping the sector, while also displacing some M&A activity.

Analysis

The first-order takeaway is not that SpaceX monetizes at an extreme multiple; it is that a successful listing would reprice the entire private defense-tech complex by creating a public-market comp set that tolerates revenue-multiple underwriting far above traditional primes. That tends to compress expected IRR for late-stage capital in the next 12-24 months, but it also lowers the cost of follow-on equity for the best-connected private names and forces strategic buyers to mark up their own equity currency. The likely near-term beneficiary is the public-space basket, especially names with credible recurring revenue and visible launch/connectivity catalysts, because investor attention will rotate from “can this industry be public?” to “which of these can sustain premium growth?”

The second-order loser is the legacy prime/supply-chain complex, but not because of direct operating displacement. The bigger issue is capital-allocation gravity: a trillion-dollar-adjacent SpaceX print would pull incremental defense-tech dollars away from mature cash generators and toward growth narratives, which can widen valuation gaps between software-like defense tech and asset-heavy primes for 6-12 months. That said, primes can actually benefit if the IPO wave validates higher sector multiples and sparks a procurement/strategic M&A reset; the more likely underappreciated effect is that public peers with strong balance sheets become consolidators of newly listed but operationally brittle companies once the market stops rewarding growth at any price.

The key risk is a post-IPO reality check: if SpaceX prices at the high end but trading performance is choppy, the read-through to every late-stage defense unicorn flips quickly from positive to cautionary. In that scenario, the market will punish any company with long-dated commercialization, heavy capex, or dependence on narrative-driven valuation support, and the fallout would show up first in the weakest-listed space names over a 3-6 month window. The contrarian view is that this is not a clean bullish signal for all aerospace/defense IPOs—an oversized flagship could actually siphon scarce risk capital into one dominant story, leaving smaller IPOs with weaker aftermarket demand than consensus expects.

Key Decisions for Investors

• Long ASTS vs short a basket of weaker pre-profitability space names on a 3-6 month horizon; thesis is that validated sector appetite will favor the best launch/connectivity execution while exposing names that still need repeated capital raises.
• Buy GE and RTX on any IPO-led multiple compression in the next 2-4 weeks; if private valuations reset public comps higher, these quality cash generators can rerate without needing step-change growth, offering lower downside than the high-beta space basket.
• Short a basket of the most narrative-dependent defense-tech exposure via options rather than stock if available; use 6-9 month puts or put spreads to express that aftermarket enthusiasm may fade after the first marquee IPO windows.
• Pair long LMT/NOC against a basket of defense-tech IPO beneficiaries if valuation spread widens further; the trade works if public-market discipline returns and investors rotate back to profitable incumbents with real free cash flow.
• Avoid chasing PL into the event unless pullbacks create a better entry; it is more likely to benefit from sentiment spillover than from immediate fundamental re-rating, so risk/reward is best only on weakness.